Market Tracker

07/28 6:45am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

7.06
Delayed Data
As of Jul 27
 -0.37 / -4.98%
Today’s Change
4.03
Today|||52-Week Range
8.38
+20.48%
Year-to-Date

Today’s Trading

Previous close7.43
Today’s open7.50
Day’s range6.83 - 7.51
Volume3,085,685
Average volume (3 months)1,446,618
Market cap$765.8M
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+55.31%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-0.25-1.20%
TGTXTG Therapeutics Inc-0.25-2.12%
FLXNFlexion Therapeutics...-0.71-2.89%
ACRSAclaris Therapeutics...-0.46-1.55%
Data as of 07/27/2017

Financials

Last reporting dateJuly 27, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts